purchase customization

1 Introduction to Research & Analysis Reports
1.1 End Stage Renal Disease Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global End Stage Renal Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global End Stage Renal Disease Drug Overall Market Size
2.1 Global End Stage Renal Disease Drug Market Size: 2023 VS 2030
2.2 Global End Stage Renal Disease Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global End Stage Renal Disease Drug Sales: 2019-2030
3 Company Landscape
3.1 Top End Stage Renal Disease Drug Players in Global Market
3.2 Top Global End Stage Renal Disease Drug Companies Ranked by Revenue
3.3 Global End Stage Renal Disease Drug Revenue by Companies
3.4 Global End Stage Renal Disease Drug Sales by Companies
3.5 Global End Stage Renal Disease Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 End Stage Renal Disease Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers End Stage Renal Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 End Stage Renal Disease Drug Players in Global Market
3.8.1 List of Global Tier 1 End Stage Renal Disease Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 End Stage Renal Disease Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global End Stage Renal Disease Drug Market Size Markets, 2023 & 2030
4.1.2 Calcimimetics
4.1.3 Vitamin D
4.1.4 Sterols
4.1.5 Potassium Binders
4.1.6 Calcium-Based Phosphate Binders
4.1.7 Other
4.2 By Type - Global End Stage Renal Disease Drug Revenue & Forecasts
4.2.1 By Type - Global End Stage Renal Disease Drug Revenue, 2019-2024
4.2.2 By Type - Global End Stage Renal Disease Drug Revenue, 2025-2030
4.2.3 By Type - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
4.3 By Type - Global End Stage Renal Disease Drug Sales & Forecasts
4.3.1 By Type - Global End Stage Renal Disease Drug Sales, 2019-2024
4.3.2 By Type - Global End Stage Renal Disease Drug Sales, 2025-2030
4.3.3 By Type - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
4.4 By Type - Global End Stage Renal Disease Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global End Stage Renal Disease Drug Market Size, 2023 & 2030
5.1.2 End Stage Renal Disease Induced Hyperparathyroidism
5.1.3 End Stage Renal Disease Induced Hyperphosphatemia
5.1.4 End Stage Renal Disease Induced Hyperkalaemia
5.2 By Application - Global End Stage Renal Disease Drug Revenue & Forecasts
5.2.1 By Application - Global End Stage Renal Disease Drug Revenue, 2019-2024
5.2.2 By Application - Global End Stage Renal Disease Drug Revenue, 2025-2030
5.2.3 By Application - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
5.3 By Application - Global End Stage Renal Disease Drug Sales & Forecasts
5.3.1 By Application - Global End Stage Renal Disease Drug Sales, 2019-2024
5.3.2 By Application - Global End Stage Renal Disease Drug Sales, 2025-2030
5.3.3 By Application - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
5.4 By Application - Global End Stage Renal Disease Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global End Stage Renal Disease Drug Market Size, 2023 & 2030
6.2 By Region - Global End Stage Renal Disease Drug Revenue & Forecasts
6.2.1 By Region - Global End Stage Renal Disease Drug Revenue, 2019-2024
6.2.2 By Region - Global End Stage Renal Disease Drug Revenue, 2025-2030
6.2.3 By Region - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
6.3 By Region - Global End Stage Renal Disease Drug Sales & Forecasts
6.3.1 By Region - Global End Stage Renal Disease Drug Sales, 2019-2024
6.3.2 By Region - Global End Stage Renal Disease Drug Sales, 2025-2030
6.3.3 By Region - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America End Stage Renal Disease Drug Revenue, 2019-2030
6.4.2 By Country - North America End Stage Renal Disease Drug Sales, 2019-2030
6.4.3 US End Stage Renal Disease Drug Market Size, 2019-2030
6.4.4 Canada End Stage Renal Disease Drug Market Size, 2019-2030
6.4.5 Mexico End Stage Renal Disease Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe End Stage Renal Disease Drug Revenue, 2019-2030
6.5.2 By Country - Europe End Stage Renal Disease Drug Sales, 2019-2030
6.5.3 Germany End Stage Renal Disease Drug Market Size, 2019-2030
6.5.4 France End Stage Renal Disease Drug Market Size, 2019-2030
6.5.5 U.K. End Stage Renal Disease Drug Market Size, 2019-2030
6.5.6 Italy End Stage Renal Disease Drug Market Size, 2019-2030
6.5.7 Russia End Stage Renal Disease Drug Market Size, 2019-2030
6.5.8 Nordic Countries End Stage Renal Disease Drug Market Size, 2019-2030
6.5.9 Benelux End Stage Renal Disease Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia End Stage Renal Disease Drug Revenue, 2019-2030
6.6.2 By Region - Asia End Stage Renal Disease Drug Sales, 2019-2030
6.6.3 China End Stage Renal Disease Drug Market Size, 2019-2030
6.6.4 Japan End Stage Renal Disease Drug Market Size, 2019-2030
6.6.5 South Korea End Stage Renal Disease Drug Market Size, 2019-2030
6.6.6 Southeast Asia End Stage Renal Disease Drug Market Size, 2019-2030
6.6.7 India End Stage Renal Disease Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America End Stage Renal Disease Drug Revenue, 2019-2030
6.7.2 By Country - South America End Stage Renal Disease Drug Sales, 2019-2030
6.7.3 Brazil End Stage Renal Disease Drug Market Size, 2019-2030
6.7.4 Argentina End Stage Renal Disease Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa End Stage Renal Disease Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa End Stage Renal Disease Drug Sales, 2019-2030
6.8.3 Turkey End Stage Renal Disease Drug Market Size, 2019-2030
6.8.4 Israel End Stage Renal Disease Drug Market Size, 2019-2030
6.8.5 Saudi Arabia End Stage Renal Disease Drug Market Size, 2019-2030
6.8.6 UAE End Stage Renal Disease Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc End Stage Renal Disease Drug Major Product Offerings
7.1.4 Pfizer Inc End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca End Stage Renal Disease Drug Major Product Offerings
7.2.4 AstraZeneca End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Company Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company End Stage Renal Disease Drug Major Product Offerings
7.3.4 Bristol-Myers Squibb Company End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.3.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.4 Dr. Reddy's Laboratories Ltd
7.4.1 Dr. Reddy's Laboratories Ltd Company Summary
7.4.2 Dr. Reddy's Laboratories Ltd Business Overview
7.4.3 Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Major Product Offerings
7.4.4 Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.4.5 Dr. Reddy's Laboratories Ltd Key News & Latest Developments
7.5 Endo International plc
7.5.1 Endo International plc Company Summary
7.5.2 Endo International plc Business Overview
7.5.3 Endo International plc End Stage Renal Disease Drug Major Product Offerings
7.5.4 Endo International plc End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.5.5 Endo International plc Key News & Latest Developments
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Teva Pharmaceutical Industries Ltd Company Summary
7.6.2 Teva Pharmaceutical Industries Ltd Business Overview
7.6.3 Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.6.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.7 Sun Pharmaceutical Industries Ltd
7.7.1 Sun Pharmaceutical Industries Ltd Company Summary
7.7.2 Sun Pharmaceutical Industries Ltd Business Overview
7.7.3 Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.7.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.8 Mylan NV
7.8.1 Mylan NV Company Summary
7.8.2 Mylan NV Business Overview
7.8.3 Mylan NV End Stage Renal Disease Drug Major Product Offerings
7.8.4 Mylan NV End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.8.5 Mylan NV Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG End Stage Renal Disease Drug Major Product Offerings
7.9.4 Novartis AG End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Lupin
7.10.1 Lupin Company Summary
7.10.2 Lupin Business Overview
7.10.3 Lupin End Stage Renal Disease Drug Major Product Offerings
7.10.4 Lupin End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.10.5 Lupin Key News & Latest Developments
7.11 Cipla Inc
7.11.1 Cipla Inc Company Summary
7.11.2 Cipla Inc End Stage Renal Disease Drug Business Overview
7.11.3 Cipla Inc End Stage Renal Disease Drug Major Product Offerings
7.11.4 Cipla Inc End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.11.5 Cipla Inc Key News & Latest Developments
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Company Summary
7.12.2 Aurobindo Pharma End Stage Renal Disease Drug Business Overview
7.12.3 Aurobindo Pharma End Stage Renal Disease Drug Major Product Offerings
7.12.4 Aurobindo Pharma End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.12.5 Aurobindo Pharma Key News & Latest Developments
7.13 Fresenius SE & Co. KGaA
7.13.1 Fresenius SE & Co. KGaA Company Summary
7.13.2 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Business Overview
7.13.3 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Major Product Offerings
7.13.4 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.13.5 Fresenius SE & Co. KGaA Key News & Latest Developments
7.14 Sanofi
7.14.1 Sanofi Company Summary
7.14.2 Sanofi Business Overview
7.14.3 Sanofi End Stage Renal Disease Drug Major Product Offerings
7.14.4 Sanofi End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.14.5 Sanofi Key News & Latest Developments
7.15 Takeda Pharmaceutical Company Limited
7.15.1 Takeda Pharmaceutical Company Limited Company Summary
7.15.2 Takeda Pharmaceutical Company Limited Business Overview
7.15.3 Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Major Product Offerings
7.15.4 Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.15.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.16 F. Hoffmann-La Roche Ltd
7.16.1 F. Hoffmann-La Roche Ltd Company Summary
7.16.2 F. Hoffmann-La Roche Ltd Business Overview
7.16.3 F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Major Product Offerings
7.16.4 F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.16.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.17 Kissei Pharmaceutical Co., Ltd
7.17.1 Kissei Pharmaceutical Co., Ltd Company Summary
7.17.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.17.3 Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Major Product Offerings
7.17.4 Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.17.5 Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
7.18 Abbott
7.18.1 Abbott Company Summary
7.18.2 Abbott Business Overview
7.18.3 Abbott End Stage Renal Disease Drug Major Product Offerings
7.18.4 Abbott End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.18.5 Abbott Key News & Latest Developments
8 Global End Stage Renal Disease Drug Production Capacity, Analysis
8.1 Global End Stage Renal Disease Drug Production Capacity, 2019-2030
8.2 End Stage Renal Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global End Stage Renal Disease Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 End Stage Renal Disease Drug Supply Chain Analysis
10.1 End Stage Renal Disease Drug Industry Value Chain
10.2 End Stage Renal Disease Drug Upstream Market
10.3 End Stage Renal Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 End Stage Renal Disease Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer